share_log

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cosmo Pharmaceuticals N.V.(13.2%),Cosmo Technologies Ltd.(13.2%)

Mar 7, 2022 17:25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more